ELEVATE 2 (RVT-1201-2002): A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients with Pulmonary Arterial Hypertension

Primary Objective

To evaluate the effect of rodatristat ethyl on the percent change from baseline pulmonary vascular resistance (PVR), as measured by right heart catheterization (RHC) in patients with PAH

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Scope

National

Locations

Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of David Badesch,  MD

David Badesch, MD

Study ID

Protocol Number: 21-3433

More information available at ClinicalTrials.gov: NCT04712669

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers